Search Results for: EXTERNAL DELIVERY Diary of a
Articles
EXTERNAL DELIVERY - Diary of a Wimpy CEO May 30, 2017
John A. Bermingham talks about his experiences working for CEOs with great strength and character, as well as those considered to be “wimps” who had very little respect from the management team.
SPECIAL FEATURE - Prefilled Syringes & Parenteral Manufacturing: A Rise in Biologics & Improved Technology Give Pharma Reasons to Consider Parenteral Delivery May 2, 2017
Contributor Cindy H. Dubin speaks with some of the leading companies in this market to find out about key trends, packaging advancements, safety improvements, and technology developments.
DRUG DISCOVERY - Benefits of Acoustic Liquid Handling in Drug Discovery February 29, 2024
John Fuller, PhD, believes automated acoustic liquid dispensing technology is a game changer – whether deployed as a stand-alone instrument, in a scaled-up workstation, or as part of fully integrated systems – when it comes to handling complexity in efficient and cost-effective ways.
Mogrify & Astellas Announce Collaboration to Conduct Research on In Vivo Regenerative Medicine Approaches to Address Sensorineural Hearing Loss July 5, 2022
Mogrify Limited and Astellas Pharma Inc. recently announced they have executed a collaborative research agreement on in vivo regenerative medicine approaches to….
Enteris BioPharma Highlighted as Game Changer in Special Feature on Innovative Technologies for Improving Drug Solubility & Bioavailability April 7, 2022
Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary...Enteris BioPharma Highlights Progress in Oral Feasibility Program February 21, 2022
Enteris BioPharma, Inc. recently provided an update on its oral feasibility programs involving the company’s Peptelligence and ProPerma oral peptide and small….
Enteris BioPharma to Participate in Biotech Showcase Virtual & BIO Partnering at JPM During J.P. Morgan Week 2022 January 20, 2022
Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary...Axovant Gene Therapies Announces FDA Clearance of IND for Gene Therapy November 11, 2020
Axovant Gene Therapies Ltd. recently announced the US FDA has lifted its clinical hold and cleared the Investigational New Drug (IND) Application to initiate a registrational study of….
EXECUTIVE INTERVIEW - Immunic Therapeutics: Developing Next-Generation Oral Drugs in Chronic Inflammatory, Autoimmune & Infectious Diseases October 1, 2020
Daniel Vitt, PhD, Immunic’s Chief Executive Officer and President, discusses his company’s pipeline of selective, small molecule therapies aimed at treating chronic inflammatory and autoimmune diseases, and its recent progress.
Enteris Biopharma Doses First Woman in Phase 2a Clinical Trial August 28, 2017
Enteris BioPharma, Inc., a biotechnology company developing innovative drug products built around its proprietary delivery technologies, recently announced the first...West Introduces LyoSeal® Instant Sealing Solution & NovaGuard® SA Pro Safety System February 1, 2017
West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, recently introduced two new offerings at...West Introduces LyoSeal® Instant Sealing Solution & NovaGuard® SA Pro Safety System February 1, 2017
West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, recently introduced two new offerings at...Merck Enters Further Global Co-Development & Commercialization Agreement With BeiGene November 19, 2013
Merck Serono recently announced that a global licensing, co-development, and commercialization agreement for BeiGene-290 has been signed with BeiGene Co.,...10/10/2012 October 7, 2012
Cleveland BioLabs & Incuron Announce Orphan Drug Status Cleveland BioLabs, Inc. and Incuron, LLC, a joint venture between the company...3/20/2012 March 15, 2012
Connell Brothers Signs Agreement With World's Top Chemical Company Connell Brothers Australasia recently announced it was appointed by BASF Australia,...12/13/2011 December 11, 2011
Abbott Laboratories Spends $400 Million on Development Deal Abbott Laboratories and Reata Pharmaceuticals recently announced they have entered into a worldwide...12/6/2011 December 4, 2011
Nanion's SyncroPatch 96 Convinces Big Pharma Automated Patch Clamp Users Nanion's ion channel screening platform, the SyncroPatch 96, has been...11/22/2011 November 20, 2011
Apricus Biosciences Announces NexACT Partner Has Completed pre-IND Meeting Apricus Biosciences, Inc. recently announced its NexACT out-licensing partner, Exodos Life...
